{"id":"https://openalex.org/W7204690227","doi":"https://doi.org/10.1016/s2152-2650(26)02548-6","title":"ABCL-241: Real-World Characteristics, Treatment Patterns, and Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated in First-Line in the United States Community Oncology Setting","display_name":"ABCL-241: Real-World Characteristics, Treatment Patterns, and Outcomes of Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated in First-Line in the United States Community Oncology Setting","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204690227","doi":"https://doi.org/10.1016/s2152-2650(26)02548-6"},"language":"en","primary_location":{"id":"doi:10.1016/s2152-2650(26)02548-6","doi":"https://doi.org/10.1016/s2152-2650(26)02548-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02548-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5132912111","display_name":"Barbara Furtado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara Furtado","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114047926","display_name":"Helen Latimer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Latimer","raw_affiliation_strings":["Ontada, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ontada, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052985669","display_name":"Anna Teschemaker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna Teschemaker","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137209977","display_name":"Marc Purazo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Purazo","raw_affiliation_strings":["AstraZeneca, Gaithersburg, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, MD, USA","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062477688","display_name":"Debbie Adkins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Debbie Adkins","raw_affiliation_strings":["AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042967384","display_name":"Ira L. Zackon","orcid":"https://orcid.org/0009-0005-8495-0277","observed_orcids":["https://orcid.org/0009-0005-8495-0277"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ira Zackon","raw_affiliation_strings":["Ontada, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ontada, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044443313","display_name":"Jinhong Guo","orcid":"https://orcid.org/0000-0001-5856-6267","observed_orcids":["https://orcid.org/0000-0001-5856-6267"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jinhong Guo","raw_affiliation_strings":["Ontada, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ontada, Boston, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5094174511","display_name":"Helen Engle","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Helen Engle","raw_affiliation_strings":["Ontada, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ontada, Boston, MA, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5126432653","display_name":"David Andorsky","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140702","display_name":"Rocky Mountain Cancer Centers","ror":"https://ror.org/03ynhs115","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210140702"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Andorsky","raw_affiliation_strings":["Rocky Mountain Cancer Centers, Boulder, CO, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rocky Mountain Cancer Centers, Boulder, CO, USA","institution_ids":["https://openalex.org/I4210140702"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3890,"currency":"USD","value_usd":3890},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.6365972,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"26","issue":null,"first_page":"S895","last_page":"S896"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/diffuse-large-b-cell-lymphoma","display_name":"diffuse large B-cell lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.8629999756813049},{"id":"https://openalex.org/keywords/r-chop","display_name":"R-CHOP","score":0.8650000095367432},{"id":"https://openalex.org/keywords/community-oncology","display_name":"community oncology","score":0.7689999938011169},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.9039999842643738},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6499999761581421},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7139999866485596},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.5600000023841858},{"id":"https://openalex.org/keywords/treatment-utilization-trends","display_name":"treatment utilization trends","score":0.5720000267028809},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.6209999918937683},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.5350000262260437},{"id":"https://openalex.org/keywords/polatuzumab","display_name":"polatuzumab","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9876000285148621},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.4884999990463257},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4706000089645386},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.4611999988555908},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4104999899864197},{"id":"https://openalex.org/C2992520072","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation oncology","level":3,"score":0.32899999618530273},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.31769999861717224},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.29089999198913574},{"id":"https://openalex.org/C2780612607","wikidata":"https://www.wikidata.org/wiki/Q5155039","display_name":"Community practice","level":3,"score":0.27790001034736633},{"id":"https://openalex.org/C61434518","wikidata":"https://www.wikidata.org/wiki/Q932510","display_name":"General surgery","level":1,"score":0.2484000027179718}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s2152-2650(26)02548-6","doi":"https://doi.org/10.1016/s2152-2650(26)02548-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s2152-2650(26)02548-6","pdf_url":null,"source":{"id":"https://openalex.org/S186546955","display_name":"Clinical Lymphoma Myeloma & Leukemia","issn_l":"2152-2650","issn":["2152-2650","2152-2669"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Lymphoma Myeloma and Leukemia","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7162660357","https://openalex.org/W4394684158","https://openalex.org/W4417013127","https://openalex.org/W4417015007","https://openalex.org/W4417014998","https://openalex.org/W2588607147","https://openalex.org/W4417020879","https://openalex.org/W7166868674","https://openalex.org/W2967762783","https://openalex.org/W4417009798"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-31T00:00:00"}